Perinatal treatment of rats with opiates affects the development of the blood-brain barrier transport system PTS-1

W A Banks1, A J Kastin, L M Harrison

  • 1Veterans Affairs Medical Center-New Orleans, LA 70146, USA.

Insights

Neonatal morphine exposure enhances peptide transport system-1 (PTS-1) activity in adult rats. This blood-brain barrier system

Area of Science:

  • Neuroscience
  • Pharmacology
  • Developmental Biology

Background:

  • Neonatal morphine exposure impacts peptide transport system-1 (PTS-1) development.
  • PTS-1 transports Tyr-MIF-1 and methionine enkephalin across the blood-brain barrier.
  • PTS-1 activity correlates with brain methionine enkephalin levels.

Purpose of the Study:

  • To investigate the long-term effects of perinatal morphine sulfate (MS) exposure on PTS-1 activity.
  • To determine the influence of different opioid receptor agonists and antagonists on PTS-1 activity.

Main Methods:

  • Rats received peripheral MS treatment during prenatal and neonatal periods.
  • PTS-1 activity was assessed in adult rats.
  • Comparative analysis with kappa and delta opioid agonists and antagonists.

Main Results:

  • Perinatal MS treatment significantly enhanced PTS-1 activity in adult rats, increasing by 66% at 9 weeks.
  • Morphine sulfate (mu agonist) was more potent than EKC (kappa) or pCl-DPDPE (delta) agonists.
  • Methylnaltrexone blocked the MS-induced enhancement of PTS-1 activity.

Conclusions:

  • Perinatal opioid exposure can permanently alter PTS-1 activity in the adult brain.
  • Developmental opioid tone influences the maturation of blood-brain barrier transport systems.
  • These findings highlight the lasting impact of early-life opioid exposure on neurodevelopment.

Related Concept Videos